Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3348571 Title: ANTICORPS À DOMAINE UNIQUE POUR LE LIGAND DU RÉCEPTEUR DE MORT CELLULAIRE PROGRAMMÉE (PD-L1) ET PROTÉINE DÉRIVÉE DE CELUI-CI

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
168322907
WO application number:
CN2016092680
Type:
European patent granted for BE
Status:
Open
Publication number:
3348571
WO publication number:
WO2017020802
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
01/08/2016
Grant date:
10/07/2024
EP publication date:
18/07/2018
WO publication date:
09/02/2017
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
10/07/2024
EP B1 publication date:
10/07/2024
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
01/08/2036

Applicant

1

Name:
Jiangsu Alphamab Biopharmaceuticals Co., Ltd.
Legal Form:
From:
10/07/2024
Address:
Rm 310, Building G No. 388 Ruoshui Road SIP, Suzhou, Jiangsu 215125, China (CN)
To:

2

Name:
3d Medicines (Beijing) Co., Ltd.
Legal Form:
From:
10/07/2024
Address:
Room 1603, Building 3 No.88 Kechuangliu Street, Beijing 100176, China (CN)
To:

Agent

Name:
KOUKOUNIS Wasilis
Legal Form:
From:
31/07/2024
Address:
Kaistrasse 16A, 40221, DÜSSELDORF, Germany (DE)
To:

Inventor

1

Name:
XU, Ting
Legal Form:
Address:
Suzhou Jiangsu, China (CN)

2

Name:
DONG, Yanrong
Legal Form:
Address:
Suzhou Jiangsu, China (CN)

3

Name:
WANG, Pilin
Legal Form:
Address:
Suzhou Jiangsu, China (CN)

4

Name:
CHEN, Ting
Legal Form:
Address:
Suzhou Jiangsu, China (CN)

Priority

Priority patent number:
201510465481
Priority date:
31/07/2015
Priority country:
China (CN)

Classification

IPC or IDT classification:
C07K 16/28; A61K 39/395; A61P 35/00; A61P 31/00; A61P 29/00; C12N 15/13; C12N 15/85; C12N 5/10;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2024/13
Publication date:
01/08/2024
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

Issue number:
202428
Publication date:
10/07/2024
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
01/09/2025
Annual fee number:
10
Annual fee amount:
185 Euro
Expected payer:
Last annual fee payment date:
26/08/2024
Last annual fee paid number:
9
Last annual fee paid amount:
165 Euro
Payer:
PAVIS GmbH
Filing date Document type Publication Type Document Description Number of pages File Type
31/07/2024 Incoming Correspondence (Post) 1 PDF /8/5/8/1/4/0722441858/docs/168322907_0_incomingcorrespondencepaper_20240731_023126913.pdf
31/07/2024 Incoming Correspondence (Post) 1 PDF /8/5/8/1/4/0722441858/docs/168322907_1_incomingcorrespondencepaper_20240731_023143682.pdf
05/08/2024 General Document Other 2 PDF /8/5/8/1/4/0722441858/docs/168322907_2_generaldocument_20240805_041057733.pdf
14/08/2024 Incoming Correspondence (Post) 1 PDF /8/5/8/1/4/0722441858/docs/168322907_3_incomingcorrespondencepaper_20240814_032746393.pdf